Tags Archives: decannulation

Perfusfind S.L.

Abstract Background ECMO-associated coagulopathy is a common phenomenon in patients undergoing ECMO therapy. However, data on coagulation trajectories in the post ECMO decannulation period are limited. This study aimed to..

Perfusfind S.L.

Abstract Assessment of readiness for venoarterial extracorporeal membrane oxygenation (VA ECMO) weaning relies on hemodynamic and metabolic parameters of cardiac and respiratory functions. Lactate clearance, inotropic support, and echocardiographic criteria,..

Perfusfind S.L.

Abstract Objectives:  In neonates, the carotid artery can be ligated or reconstructed at the time of decannulation from venoarterial extracorporeal membrane oxygenation (VA-ECMO). However, there is a paucity of data..

Perfusfind S.L.

Abstract Objectives:  Decannulation after pediatric extracorporeal life support (ECLS) may be accompanied by arterial reconstruction. There is a paucity of data on arterial morphology following reconstruction. We sought to characterize..

Perfusfind S.L.

We present an enhanced percutaneous decannulation technique for a patient undergoing  veno-arterial extracorporeal membrane oxygenation. This innovative approach uses two distinct percutaneous vascular devices, offering a more reliable and more..

Perfusfind S.L.

Abstract Purpose Fever is frequent after extracorporeal membrane oxygenation (ECMO) decannulation. We aimed to evaluate the incidence of post-decannulation fever and describe its causes. Methods Adult ECMO patients who were..

Perfusfind S.L.

Abstract Background Clinical blood resources are scarce and autologous blood transfusion for extracorporeal membrane oxygenation (ECMO) withdrawal is less studied. Objectives To assess the use of staged autotransfusion during ECMO..

Perfusfind S.L.

Abstract Background Clinical blood resources are scarce and autologous blood transfusion for extracorporeal membrane oxygenation (ECMO) withdrawal is less studied. Objectives To assess the use of staged  during  decannulation. Methods The study..

Perfusfind S.L.

Abstract Background: Venovenous extracorporeal membrane oxygenation (VV-ECMO) is a therapy for patients with refractory respiratory failure. The decision to decannulate someone from extracorporeal membrane oxygenation (ECMO) often involves weaning trials..

Perfusfind S.L.

Abstract Objective Although  (ECLS) has increasingly been used for the  of patients with  (CS), the outcomes of those successfully weaned from support remain poorly defined. Methods Of 510 venoarterial ECLS CS patients at..

Perfusfind S.L.

Abstract Decannulation of patients on peripheral veno-arterial extracorporeal membrane oxygenation (VA ECMO) typically involves femoral arterial cutdown and surgical arteriotomy closure in an operating room under general anesthesia. However, this..

Perfusfind S.L.

Abstract Percutaneous cannulation improved femoro-femoral veno-arterial Extracorporeal Membrane Oxygenation (VA-ECMO) results, reducing infectious complications, but remains limited by vascular complications related to the arterial decannulation. Several techniques were described to perform a percutaneous decannulation..

Perfusfind S.L.

Abstract Purpose A survival gap between weaning from venoarterial-extracorporeal membrane oxygenation (VA-ECMO) and the hospital discharge has been consistently reported. The aim of this study is to investigate the clinical..

Perfusfind S.L.

ABSTRACT In 1952, John Gibbon performed the first successful cardiac procedure using cardiopulmonary bypass, which turned out to be one of the most important clinical advances of that year. Cardiopulmonary..